Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study

This article has no abstract
Epistemonikos ID: ef01371ee63c301ed58e5ea57f91d67d170f53dd
First added on: Feb 19, 2025